Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
JAMA Network Open|April 6, 2021
Trends in Female Authorship in Major Journals of 3 Oncology Disciplines, 2002-2018Anirudh Yalamanchali, Emily S Zhang, Reshma Jagsi
JCO Oncology Practice|November 20, 2025
Return to Intended Oncologic Therapy in Patients With Metastatic Non-Small Cell Lung Cancer Discharged to a Skilled Nursing FacilityAnirudh Yalamanchali, Preeyal Patel, Ali Mushtaq, et al.
The Journal of Physical Chemistry. A|July 1, 2014
Melting of size-selected gallium clusters with 60-183 atomsKatheryne L Pyfer, Jared O Kafader, Anirudh Yalamanchali, et al.
Radiation Research|November 2, 2019
Comprehensive Analysis of the Kinetics of Radiation-Induced Lymphocyte Loss in Patients Treated with External Beam Radiation TherapySusannah G Ellsworth, Anirudh Yalamanchali, Hong Zhang, et al.
Advances in Radiation Oncology|August 5, 2022
Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation TherapySusannah G Ellsworth, Anirudh Yalamanchali, Tim Lautenschlaeger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2019
A framework for modeling radiation induced lymphopenia in radiotherapyJian-Yue Jin, Todd Mereniuk, Anirudh Yalamanchali, et al.
World Journal of Clinical Oncology|August 11, 2022
Epstein-Barr virus-associated smooth muscle tumors in immunocompromised patients: Six case reportsAfshin A Khan, Bassam N Estfan, Anirudh Yalamanchali, et al.
Advances in Radiation Oncology|March 5, 2021
Patient-Specific Lymphocyte Loss Kinetics as Biomarker of Spleen Dose in Patients Undergoing Radiation Therapy for Upper Abdominal MalignanciesAnirudh Yalamanchali, Hong Zhang, Ke Colin Huang, et al.
British Journal of Haematology|January 6, 2023
External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugsDanai Dima, Ang Li, Lauren M Granat, et al.
Head & Neck|February 22, 2023
Comparison of real-world outcomes following immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma with outcomes of randomized controlled trialsAnirudh Yalamanchali, Kailin Yang, Logan Roof, et al.
Pageof 2